Erectile dysfunction is not independently associated with cardiovascular death: data from the vitamins and lifestyle

James M Hotaling1, Thomas J Walsh, Liam Connor Macleod

  • 1Department of Urology, University of Washington, Seattle, WA 98195, USA.

Insights

Erectile dysfunction (ED) in men is not an independent predictor of cardiovascular death. Once other cardiovascular disease risk factors are accounted for, ED does not increase the risk of dying from heart disease.

Area of Science:

  • Cardiology
  • Urology
  • Public Health

Background:

  • Erectile dysfunction (ED) is a common issue in aging men and is linked to cardiovascular (CV) events.
  • Existing research shows an association between ED and CV events like heart attack and stroke.

Purpose of the Study:

  • To investigate whether ED is associated with an increased risk of cardiovascular death.
  • To determine if ED independently predicts CV mortality in men.

Main Methods:

  • A cohort of 31,296 men aged 50-76 in Washington State completed a health questionnaire, including an ED assessment.
  • Participants were tracked for CV death through the Washington State Death Certificate System from 2000-2008.
  • Multivariate Cox proportional hazard regression was used to analyze the risk of CV death, adjusting for numerous CV risk factors.

Main Results:

  • Approximately 7,762 men reported ED, and 486 experienced CV death during an average follow-up of 7.8 years.
  • Initially, ED was associated with a 23% increased risk of CV death (HR 1.23, 95% CI 1.01, 1.49).
  • After adjusting for established CV disease risk factors, ED was no longer a significant predictor of CV death (HR 0.93, 95% CI 0.76, 1.15).

Conclusions:

  • In this cohort, ED was not independently associated with an increased risk of cardiovascular death.
  • The findings suggest that ED may be a symptom reflecting underlying, known risk factors for cardiovascular disease rather than an independent risk factor itself.
Abstract

Related Concept Videos

Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...